Reimbursed with a limitationOriginator productATC R03AL11

Trixeo Aerosphere

Trixeo Aerosphere is an originator product from AstraZeneca AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 74.15 to CHF 189.70 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
AstraZeneca AG
ATC code
R03AL11
IT group
03.04.30 Sympathicomimetica und Parasympathicolytica
Active substances
Formoteroli fumaras dihydricus, Glycopyrronium, Budesonidum
Preparation type
Originator product
On the SL since
01/06/2022
Last price change
01/02/2026
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Trixeo Aerosphere Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Inhalator 5/7.2/160 mcg120 DosCHF 53.10CHF 74.1501/06/2022B7680683880026
Inhalator 5/7.2/160 mcg3 x 120 DosCHF 159.31CHF 189.7001/01/2023B7680683880033

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/06/2022

Für Patienten mit moderater COPD nach ≥ 1 moderaten Exazerbation pro Jahr trotz einer mindestens 3 Monate dauernder optimierter Therapie unter LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/μl, welche nicht ausreichend eingestellt sind
oder
für Patienten mit moderater bis schwerer COPD nach ≥ 2 moderaten Exazerbationen pro Jahr oder ≥ 1 Exazerbation pro Jahr, welche zu einer Hospitalisation geführt hat trotz einer mindestens 3 Monaten dauernden optimierter Therapie unter ICS/LABA oder LABA/LAMA (für LABA/LAMA mit Eosinophilenzellzahl im Blut ≥ 100 Zellen/μl), welche nicht ausreichend eingestellt sind
oder
für Patienten mit COPD, welche bereits mit einer Dreifach-Kombination bestehend aus LABA, ICS und LAMA mit einem oder mehreren Inhalatoren therapiert werden.

FAQ

Is Trixeo Aerosphere covered by Swiss health insurance?

Yes, but only under conditions. Trixeo Aerosphere is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Trixeo Aerosphere cost in Switzerland?

The public price is the maximum price set by the FOPH and for Trixeo Aerosphere ranges from CHF 74.15 to CHF 189.70 per pack. The ex-factory price ranges from CHF 53.10 to CHF 159.31. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com